[(3S,8S,9S,10R,13S,14S,17S)-17-[(E)-3-(2,4-dimethoxyphenyl)prop-2-enoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate

C32H42O5 — CID 71615649

IUPAC[(3S,8S,9S,10R,13S,14S,17S)-17-[(E)-3-(2,4-dimethoxyphenyl)prop-2-enoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
SMILESCOc1ccc(/C=C/C(=O)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](OC(C)=O)CC[C@]5(C)[C@H]4CC[C@]23C)c(OC)c1
InChIInChI=1S/C32H42O5/c1-20(33)37-24-14-16-31(2)22(18-24)8-10-25-26-11-12-28(32(26,3)17-15-27(25)31)29(34)13-7-21-6-9-23(35-4)19-30(21)36-5/h6-9,13,19,24-28H,10-12,14-18H2,1-5H3/b13-7+/t24-,25-,26-,27-,28+,31-,32-/m0/s1
InChIKeyVJYFXIJAWUXSRC-VJIHWLDESA-N
MW506.68 g/mol
LogP6.80
Rot. Bonds6

About [(3S,8S,9S,10R,13S,14S,17S)-17-[(E)-3-(2,4-dimethoxyphenyl)prop-2-enoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate

[(3S,8S,9S,10R,13S,14S,17S)-17-[(E)-3-(2,4-dimethoxyphenyl)prop-2-enoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate (PubChem CID 71615649) has the molecular formula C32H42O5 and a molecular weight of 506.68 g/mol. Its IUPAC name is [(3S,8S,9S,10R,13S,14S,17S)-17-[(E)-3-(2,4-dimethoxyphenyl)prop-2-enoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate.

Molecular Properties

Compound Name[(3S,8S,9S,10R,13S,14S,17S)-17-[(E)-3-(2,4-dimethoxyphenyl)prop-2-enoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
PubChem CID71615649
Molecular FormulaC32H42O5
Molecular Weight506.68 g/mol
Exact Mass506.30
IUPAC Name[(3S,8S,9S,10R,13S,14S,17S)-17-[(E)-3-(2,4-dimethoxyphenyl)prop-2-enoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
SMILESCOc1ccc(/C=C/C(=O)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](OC(C)=O)CC[C@]5(C)[C@H]4CC[C@]23C)c(OC)c1
InChIInChI=1S/C32H42O5/c1-20(33)37-24-14-16-31(2)22(18-24)8-10-25-26-11-12-28(32(26,3)17-15-27(25)31)29(34)13-7-21-6-9-23(35-4)19-30(21)36-5/h6-9,13,19,24-28H,10-12,14-18H2,1-5H3/b13-7+/t24-,25-,26-,27-,28+,31-,32-/m0/s1
InChIKeyVJYFXIJAWUXSRC-VJIHWLDESA-N
XLogP6.80
TPSA61.83 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms37
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500506.68
LogP ≤ 56.80
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze [(3S,8S,9S,10R,13S,14S,17S)-17-[(E)-3-(2,4-dimethoxyphenyl)prop-2-enoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(3S,8S,9S,10R,13S,14S,17S)-17-[(E)-3-(2,4-dimethoxyphenyl)prop-2-enoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate?
The IUPAC name of [(3S,8S,9S,10R,13S,14S,17S)-17-[(E)-3-(2,4-dimethoxyphenyl)prop-2-enoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate (CID 71615649) is [(3S,8S,9S,10R,13S,14S,17S)-17-[(E)-3-(2,4-dimethoxyphenyl)prop-2-enoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate.
What is the SMILES notation for [(3S,8S,9S,10R,13S,14S,17S)-17-[(E)-3-(2,4-dimethoxyphenyl)prop-2-enoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate?
The canonical SMILES for [(3S,8S,9S,10R,13S,14S,17S)-17-[(E)-3-(2,4-dimethoxyphenyl)prop-2-enoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate is COc1ccc(/C=C/C(=O)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](OC(C)=O)CC[C@]5(C)[C@H]4CC[C@]23C)c(OC)c1.
What is the InChIKey of [(3S,8S,9S,10R,13S,14S,17S)-17-[(E)-3-(2,4-dimethoxyphenyl)prop-2-enoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate?
The InChIKey is VJYFXIJAWUXSRC-VJIHWLDESA-N. The full InChI is InChI=1S/C32H42O5/c1-20(33)37-24-14-16-31(2)22(18-24)8-10-25-26-11-12-28(32(26,3)17-15-27(25)31)29(34)13-7-21-6-9-23(35-4)19-30(21)36-5/h6-9,13,19,24-28H,10-12,14-18H2,1-5H3/b13-7+/t24-,25-,26-,27-,28+,31-,32-/m0/s1.
What are the key properties of [(3S,8S,9S,10R,13S,14S,17S)-17-[(E)-3-(2,4-dimethoxyphenyl)prop-2-enoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate?
[(3S,8S,9S,10R,13S,14S,17S)-17-[(E)-3-(2,4-dimethoxyphenyl)prop-2-enoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate has a molecular weight of 506.68 g/mol, XLogP of 6.80, 6 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [(3S,8S,9S,10R,13S,14S,17S)-17-[(E)-3-(2,4-dimethoxyphenyl)prop-2-enoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate is sourced from PubChem (CID 71615649), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).